Table 2 Individual situation analysis
From: Establishing a prediction model for recurrence of condyloma acuminatum
Variables | Recurrence group (n = 84) | Non-recurrence group (n = 72) | χ2 | P |
|---|---|---|---|---|
Sexual partner with HPV infection, n (%) | ||||
Yes | 63 (75.0) | 26 (36.1) | 23.929 | < 0.001 |
No | 21 (25.0) | 46 (63.9) | ||
Condom use, n (%) | ||||
Yes | 22 (26.2) | 45 (62.5) | 20.860 | < 0.001 |
No | 62 (73.8) | 27 (37.5) | ||
Number of warts, n (%) | ||||
Average number of warts | 5.3 ± 3.5 | 3.3 ± 3.0 | – | < 0.001 |
≤ 3 | 18 (21.4) | 50 (69.5) | ||
4–10 | 55 (65.5) | 17 (23.6) | ||
≥ 10 | 6 (7.1) | 5 (6.9) | ||
Complicated with genitourinary diseases, n (%) | ||||
Yes | 32 (38.1) | 8 (11.1) | 14.806 | < 0.001 |
No | 52 (61.9) | 64 (88.9) | ||
Bacterial vaginitis | 7 (8.3) | 4 (5.5) | ||
Candida vaginitis | 1 (1.2) | 1 (1.4) | ||
Gonorrhea | 4 (4.8) | 1 (1.4) | ||
Pelvic effusion | 4 (4.8) | 0 (0) | ||
Urethritis | 5 (5.8) | 0 (0) | ||
Prepuce balanitis | 11 (13.2) | 2 (2.8) | ||
Other diseases with HPV infection, n (%) | ||||
Yes | 27 (32.1) | 5 (6.9) | 15.098 | < 0.001 |
No | 57 (67.9) | 67 (93.1) | ||
Filamentous wart | 11 (13.1) | 3 (4.1) | ||
Flat Wart | 9 (10.6) | 1 (1.4) | ||
Verruca vulgaris | 2 (2.4) | 1 (1.4) | ||
Finger wart | 3 (3.6) | 0 (0) | ||
Toe wart | 2 (2.4) | 0 (0) | ||
The location of the wart, n (%) | ||||
Vulva | 39 (46.4) | 24 (33.3) | 2.761 | 0.097 |
Intra-anal or intravaginal | 45 (53.6) | 48 (66.7) | ||
Typing of HPV, n (%) | ||||
High-risk type | 16 (19.0) | 22 (30.6) | 5.972 | 0.05 |
Low-risk type | 35 (41.7) | 34 (47.2) | ||
Hybrid | 33 (39.3) | 16 (22.2) | ||